Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments

Novartis Investigative Site, Leuven

Novartis Investigative Site, Liège

Novartis Investigative Site, Debrecen

Novartis Investigative Site, Zurich

Novartis Investigative Site, Taipei

Columbia University Medical Center, New York

Novartis Investigative Site, Bangkok

Novartis Investigative Site, Marseille

Novartis Investigative Site, Marseille

Novartis Investigative Site, Rozzano

Novartis Investigative Site, Milan

Novartis Investigative Site, Milan

Novartis Investigative Site, Milan

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Aviano

Novartis Investigative Site, Modena

Novartis Investigative Site, Essen

Novartis Investigative Site, Valencia

Novartis Investigative Site, Chiang Mai

Novartis Investigative Site, Siena

Novartis Investigative Site, Lille

Novartis Investigative Site, Heidelberg

Novartis Investigative Site, Lyon

MD Anderson Cancer Center Uni of Te, Houston

Novartis Investigative Site, Napoli

Novartis Investigative Site, Ulm

Novartis Investigative Site, Songkhla

Novartis Investigative Site, Villejuif

Providence Portland Medical Center, Portland

Novartis Investigative Site, Guangzhou

Novartis Investigative Site, Guangzhou

Novartis Investigative Site, Hong Kong

Novartis Investigative Site, Pokfulam

Novartis Investigative Site, Toronto

Novartis Investigative Site, Montreal

Novartis Investigative Site, Brno

Novartis Investigative Site, Jena

Novartis Investigative Site, High West

Novartis Investigative Site, Budapest

Novartis Investigative Site, Leiden

Novartis Investigative Site, Gdansk

Novartis Investigative Site, Poznan

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, L'Hospitalet de Llobregat

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Barcelona